PSMA PET-CT in Patients With High-Risk Prostate Cancer Before Curative-Intent Surgery or Radiotherapy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Prostate-Specific Membrane Antigen PET-CT in Patients With High-Risk Prostate Cancer Before Curative-Intent Surgery or Radiotherapy (proPSMA): A Prospective, Randomised, Multi-Centre Study
Lancet 2020 Mar 20;[EPub Ahead of Print], MS Hofman, N Lawrentschuk, RJ Francis, C Tang, I Vela, P Thomas, N Rutherford, JM Martin, M Frydenberg, R Shakher, LM Wong, K Taubman, S Ting Lee, E Hsiao, P Roach, M Nottage, I Kirkwood, D Hayne, E Link, P Marusic, A Matera, A Herschtal, A Iravani, RJ Hicks, S Williams, DG Murphy,From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.